DISPOSITION OF ORAL METRONIDAZOLE IN HEPATIC CIRRHOSIS AND IN HEPATOSPLENIC SCHISTOSOMIASIS

被引：28

作者：

DANESHMEND, TK

HOMEIDA, M

KAYE, CM

ELAMIN, AA

ROBERTS, CJC

机构：

[1] UNIV KHARTOUM,FAC MED,DEPT MED,KHARTOUM,SUDAN

[2] MAY & BAKER LTD,CLIN ASSAY UNIT,DAGENHAM RM10 7XS,ESSEX,ENGLAND

来源：

GUT | 1982年 / 23卷 / 10期

关键词：

D O I：

10.1136/gut.23.10.807

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：807 / 813

页数：7

共 18 条

[11] METABOLISM OF METRONIDAZOLE (1-2'-HYDROXYETHYL-2-METHYL-5-NITROIMIDAZOLE) [J].

INGS, RMJ ;

LAW, GL ;

PARNELL, EW .

BIOCHEMICAL PHARMACOLOGY, 1966, 15 (05) :515-&

[12] A RAPID AND SPECIFIC SEMI-MICRO METHOD INVOLVING HIGH-PRESSURE LIQUID-CHROMATOGRAPHY FOR THE ASSAY OF METRONIDAZOLE IN PLASMA, SALIVA, SERUM, URINE AND WHOLE-BLOOD [J].

KAYE, CM ;

SANKEY, MG ;

THOMAS, LA .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (05) :528-529

[13] BILIARY AND RENAL EXCRETION, HEPATIC-METABOLISM, AND HEPATIC SUBCELLULAR-DISTRIBUTION OF METRONIDAZOLE IN RAT [J].

LARUSSO, NF ;

LINDMARK, DG ;

MULLER, M .

BIOCHEMICAL PHARMACOLOGY, 1978, 27 (18) :2247-2254

[14] BIOAVAILABILITY OF METRONIDAZOLE IN FASTING AND NON-FASTING HEALTHY SUBJECTS AND IN PATIENTS WITH CROHNS-DISEASE [J].

MELANDER, A ;

KAHLMETER, G ;

KAMME, C ;

URSING, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 12 (01) :69-72

[15] TREATMENT OF HEPATIC-ENCEPHALOPATHY WITH METRONIDAZOLE [J].

MORGAN, MH ;

READ, AE ;

SPELLER, DCE .

GUT, 1982, 23 (01) :1-7

[16]

SIDDIQUI WH, 1979, ARCH INT PHARMACOD T, V239, P4

[17]

STAMBAUGH JE, 1968, J PHARMACOL EXP THER, V161, P373

[18]

[No title captured]

← 1 2 →